Androgen Receptor in Prostate Cancer

Cites (419)

Items 201–400 of 419

1. Compilation of somatic mutations of theCDKN2 gene in human cancers: Non-random distribution of base substitutions
   Pamela M. Pollock, John V. Pearson, Nicholas K. Hayward · 1996 · Genes Chromosomes and Cancer
2. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
   Jin Gao, Julia T. Arnold, John T. Isaacs · 2001 · PubMed
3. Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line.
   Poulin, Richard, Baker, Denis, Labrie, Fernand · 1988 · Breast Cancer Research and Treatment
4. p300 mediates androgen-independent transactivation of the androgen receptor by interleukin 6.
   José Daniel Debes, Lucy J. Schmidt, Haojie Huang, Donald J. Tindall · 2002 · PubMed
5. Gene amplification and tumor progression
   Olivier Brison · 1993 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
6. Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium
   Michael Stanbrough, Irwin Leav, Paul Kwan, Glenn J. Bubley, Steven P. Balk · 2001 · Proceedings of the National Academy of Sciences
7. Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells.
   S. Yeh, Yueh-Chiang Hu, M. Rahman, Hui-Kuan Lin, Cheng-Lung Hsu, H. Ting, Hong-Yo Kang, Chawnshang Chang · 2000 · Proceedings of the National Academy of Sciences of the United States of America
8. Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expression.
   Din‐Lii Lin, Mary C. Whitney, Zhi Yao, Evan T. Keller · 2001 · PubMed
9. Detection and analysis of ?-catenin mutations in prostate cancer
   Dennis R. Chesire, Charles M. Ewing, Jurga Sauvageot, G. Steven Bova, William B. Isaacs · 2000 · The Prostate
10. Significance of tumour-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumour angiogenesis and prognosis in endometrial carcinomas
    Helga Birgitte Salvesen, Lars A. Akslen · 1999 · International Journal of Cancer
11. Interleukin-6 differentially regulates androgen receptor transactivation via PI3K-Akt, STAT3, and MAPK, three distinct signal pathways in prostate cancer cells
    Lin Yang, Liang Wang, Hui‐Kuan Lin, Pu‐Yeh Kan, Shaozhen Xie, Meng-Yin Tsai, Peng‐Hui Wang, Yen-Ta Chen, Chawnshang Chang · 2003 · Biochemical and Biophysical Research Communications
12. Non-SH2 Domains within Insulin Receptor Substrate-1 and SHC Mediate Their Phosphotyrosine-dependent Interaction with the NPEY Motif of the Insulin-like Growth Factor I Receptor
    Ann Craparo, Thomas J. O’Neill, Thomas A. Gustafson · 1995 · Journal of Biological Chemistry
13. Transcriptional activation and transient expression of the human androgen receptor
    Tianshu Gao, Marco Marcelli, Michael John McPhaul · 1996 · The Journal of Steroid Biochemistry and Molecular Biology
14. Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor
    Lawrence E. Heisler, Andreas I. Evangelou, April M. Lew, John Trachtenberg, Harry P. Elsholtz, Theodore J. Brown · 1997 · Molecular and Cellular Endocrinology
15. Microsatellite Mutation (Cag24→18) in the Androgen Receptor Gene in Human Prostate Cancer
    Mark Schoenberg, Janette M. Hakimi, S.P. Wang, G. Steven Bova, Jonathan I. Epstein, Kenneth H. Fischbeck, William B. Isaacs, Patrick C. Walsh, Evelyn R. Barrack · 1994 · Biochemical and Biophysical Research Communications
16. Amplification and overexpression of peroxisome proliferatoractivated receptor binding protein ( PBP/PPARBP ) gene in breast cancer
    Yijun Zhu, Chao Qi, Sanjay R. Jain, Michelle M. Le Beau, Rafael Espinosa, G. Brandon Atkins, Mitchell A. Lazar, Anjana V. Yeldandi, Mahendra S. Rao, Janardan K. Reddy · 1999 · Proceedings of the National Academy of Sciences
17. Contribution of the Androgen Receptor to Prostate Cancer Predisposition and Progression
    Grant Buchanan, Ryan A. Irvine, Gerhard A. Coetzee, Wayne D. Tilley · 2001 · Cancer and Metastasis Reviews
18. Differential expression of genes induced by resveratrol in LNCaP cells: P53‐mediated molecular targets
    Bhagavathi A. Narayanan, Narayanan K. Narayanan, Gian G. Re, Daniel W. Nixon · 2003 · International Journal of Cancer
19. Characterization of the Prostate-specific Antigen gene: A novel human kallikrein-like gene
    Peter H. J. Riegman, R.J. Vlietstra, J.A.G.M. van der Korput · 1989 · Biochemical and Biophysical Research Communications
20. Expression of p160erbB-3 and p185erbB-2 in Prostatic Intraepithelial Neoplasia and Prostatic Adenocarcinoma
    Russell B. Myers, Sudhir Srivastava, Denise K. Oelschlager · 1994 · JNCI Journal of the National Cancer Institute
21. Symptom reporting in cancer patients: The role of negative affect and experienced social stigma
    M. Koller, Jochen Kussman, W. Lorenz, M. Jenkins, Margaret Voss, E. Arens, Erika Richter, Matthias Rothmund · 1996 · Cancer
22. Expression of the c-erbB-2 (Her-2/neu) Oncoprotein in Human Prostatic Carcinoma
    Eric J. Kuhn, Richard A. Kurnot, Isabell A. Sesterhenn, Esther H. Chang, Judd W. Moul · 1993 · The Journal of Urology
23. Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumors.
    Patrick Westin, Pär Stattin, Jan‐Erik Damber · 1995 · PubMed
24. Androgen-induced recruitment of RNA polymerase II to a nuclear receptor–p160 coactivator complex
    Maggie C. Louie, Hong Qiong Yang, Ai‐Hong Ma, Wei Xu, June X. Zou, Hsing-Jien Kung, Hong-Wu Chen · 2003 · Proceedings of the National Academy of Sciences
25. Nuclear Localization of Androgen Receptor In Heterogeneous Samples Of Normal, Hyperplastic And Neoplastic Human Prostate
    Gerald W. Chodak, David M. Kranc, Libertad A. Puy, Hiroyuki Takeda, Kathryn L. Johnson, Chawnshang Chang · 1992 · The Journal of Urology
26. Linkage and Association Studies of Prostate Cancer Susceptibility: Evidence for Linkage at 8p22-23
    Jianfeng Xu, Siqun L. Zheng, Gregory A. Hawkins, Dennis Faith, Brian Kelly, Sarah D. Isaacs, Kathleen E. Wiley, Bao‐Li Chang, Charles M. Ewing, Piroska Bujnovszky et al. · 2001 · The American Journal of Human Genetics
27. Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells
    Yu Zhang, Jing Ni, Edward M. Messing, Eugene B. Chang, Chin-Rang Yang, Shuyuan Yeh · 2002 · Proceedings of the National Academy of Sciences
28. Breast and Prostate Cancer: An Analysis of Common Epidemiological, Genetic, and Biochemical Features
    Carlos López-Otı́n · 1998 · Endocrine Reviews
29. From transforming growth factor-β signaling to androgen action: Identification of Smad3 as an androgen receptor coregulator in prostate cancer cells
    Hong‐Yo Kang, Hui‐Kuan Lin, Yueh‐Chiang Hu, Shuyuan Yeh, Ko‐En Huang, Chawnshang Chang · 2001 · Proceedings of the National Academy of Sciences
30. ANDROGEN RECEPTOR GENE AMPLIFICATION AT PRIMARY PROGRESSION PREDICTS RESPONSE TO COMBINED ANDROGEN BLOCKADE AS SECOND LINE THERAPY FOR ADVANCED PROSTATE CANCER
    Christian Palmberg, Pasi A. Koivisto, Laura Kakkola, Teuvo L.J. Tammela, Olli Kallioniemi, Tapio Visakorpi · 2000 · The Journal of Urology
31. Transforming growth factor-? in benign and malignant prostate
    Chung Lee, Sharon M. Sintich, Eric P. Mathews, Ali Haider Shah, SHILAJIT D. KUNDU, Kent T. Perry, Jin Seon Cho, Kenneth Yerro Ilio, Marcus Victor Cronauer, Lynn Janulis et al. · 1999 · The Prostate
32. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk
    Ola Bratt, Åke Borg, Ulf Kristoffersson · 1999 · British Journal of Cancer
33. Growth Factors Signal to Steroid Receptors through Mitogen-activated Protein Kinase Regulation of p160 Coactivator Activity
    Gabriela N. Lopez, Christoph W. Turck, Fred Schaufele, Michael R. Stallcup, Peter J. Kushner · 2001 · Journal of Biological Chemistry
34. Functional analysis of 44 mutant androgen receptors from human prostate cancer.
    Xu Shi, Ai‐Hong Ma, Liang Ping Xia, Hsing-Jien Kung, Ralph Devere White · 2002 · PubMed
35. p53, bcl-2 and Retinoblastoma Proteins as Long-Term Prognostic Markers in Localized Carcinoma of the Prostate
    Dan Theodorescu, Stanford R. Broder, James C. Boyd · 1997 · The Journal of Urology
36. A Critical Role for Phosphoinositide 3-Kinase Upstream of Gab1 and SHP2 in the Activation of Ras and Mitogen-activated Protein Kinases by Epidermal Growth Factor
    Armelle Yart, Muriel Laffargue, Patrick Mayeux, Stany Chrétien, Christine Peres, Nicholas K. Tonks, Serge Roche, Bernard Payrastre, Hugues Chap, Patrick Raynal · 2001 · Journal of Biological Chemistry
37. Δ 5 -Androstenediol is a natural hormone with androgenic activity in human prostate cancer cells
    Hiroshi Miyamoto, Shuyuan Yeh, Henry A. Lardy, Edward M. Messing, Chawnshang Chang · 1998 · Proceedings of the National Academy of Sciences
38. Family History and Prostate Cancer Risk
    Samuel M. Lesko, Lynn A. Rosenberg, Samuel Shapiro · 1996 · American Journal of Epidemiology
39. Androgen receptor status of lymph node metastases from prostate cancer
    Alfred Hobisch, Zoran Čulig, Christian Radmayr, Georg Bartsch, Helmut Klocker, A Hittmair · 1996 · The Prostate
40. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3′-kinase pathway.
    Miyake, Hideaki, Nelson, Colleen, Rennie, Paul S., Gleave, Martin E. · 2000 · Endocrinology
41. (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French–German population
    Lina S. Correa-Cerro, Gudrun Wöhr, Jürgen Häussler, Philippe Berthon, E. Drelon, Philippe Mangin, Georges Fournier, Olivier Cussenot, Petra Kraus, Walter Just et al. · 1999 · European Journal of Human Genetics
42. Androgen-induced inhibition of cell proliferation in an androgen-insensitive prostate cancer cell line (PC-3) transfected with a human androgen receptor complementary DNA.
    S Yuan, John Trachtenberg, Gordon Brent Mills, Theodore J. Brown, Fong Xu, Armand Keating · 1993 · PubMed
43. ErbB kinases and NDF signaling in human prostate cancer cells
    Adam W. Grasso, Duanzhi Wen, Casey M. Miller · 1997 · Oncogene
44. Re: Prostate Cancer and the Androgen Receptor
    Gerhard A. Coetzee, R K Ross · 1994 · JNCI Journal of the National Cancer Institute
45. Mutated human androgen receptor gene detected in a prostatic cancer patient is also activated by estradiol
    Jussi P. Elo, Linda J. Kvist, Katri A. Leinonen, Veli V. ISOMAA, Pirkko M. A. Henttu, Olavi A. Lukkarinen, Pirkko Vihko · 1995 · The Journal of Clinical Endocrinology & Metabolism
46. Trinucleotide repeats in the human androgen receptor: a molecular basis for disease
    Catherine S. Choong, Wilson Em · 1998 · Journal of Molecular Endocrinology
47. Clinical and Pathobiological Effects of Neoadjuvant Total Androgen Ablation Therapy on Clinically Localized Prostatic Adenocarcinoma
    Octavio A. Armas, Armen Garo Aprikian, Jonathan Melamed · 1994 · The American Journal of Surgical Pathology
48. Repressors of Androgen and Progesterone Receptor Action
    Irina U. Agoulnik, William C. Krause, William E. Bingman, Hassan Rahman, Mojghan Amrikachi, Gustavo E. Ayala, Nancy L. Weigel · 2003 · Journal of Biological Chemistry
49. Strong expression of the lymphoattractant C-X-C chemokine Mig is associated with heavy infiltration of T cells in human malignant melanoma
    Manfred Kunz, Atiye Toksoy, Matthias Goebeler, E. Engelhardt, Eva-Bettina Br�cker, Reinhard Gillitzer · 1999 · The Journal of Pathology
50. Mechanism of action and pure antiandrogenic properties of flutamide
    Fernand Labrie · 1993 · Cancer
51. The Functional Synergy Between IL-12 and IL-2 Involves p38 Mitogen-Activated Protein Kinase and Is Associated with the Augmentation of STAT Serine Phosphorylation
    Jared Gollob, Claudia P. Schnipper, Erin A. Murphy, Jerome Ritz, David A. Frank · 1999 · The Journal of Immunology
52. Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer
    Nosratollah Zarghami, Linda Grass, Eleftherios P. Diamandis · 1997 · British Journal of Cancer
53. Colonic mucosal proliferation is related to serum deoxycholic acid levels
    Thomas Ochsenkühn, Ekkehard Bayerdörffer, Alexander G. Meining, Matthias Schinkel, Christian Thiede, Volkmar Nüssler, Michael F. Sackmann, Rudolf Alexander Hatz, Andreas Neubauer, Gustav Paumgartner · 1999 · Cancer
54. Insulin-like growth factors and prostate cancer
    Bob Djavan, Matthias Waldert, Christian Seitz, Michael Marberger · 2001 · World Journal of Urology
55. Familial Prostate Cancer
    Janet L. Stanford, Elaine A. Ostrander · 2001 · Epidemiologic Reviews
56. Androgen Receptor Mutations in Prostate Cancer
    Edward Paul Gelmann · 1996 · Cancer treatment and research
57. Vascular density is a predictor of cancer-specific survival in prostatic carcinoma
    Ingela Franck Lissbrant, Pär E. Stattin, Jan‐Erik Damber, Anders R. J. Bergh · 1997 · The Prostate
58. Retinoblastoma, a Tumor Suppressor, Is a Coactivator for the Androgen Receptor in Human Prostate Cancer DU145 Cells
    Shuyuan Yeh, Hiroshi Miyamoto, Kazuo Nishimura, Hongyo Kang, John W. Ludlow, Pei‐Wen Hsiao, Chihuei Wang, Ching-Yuan Su, Chawnshang Chang · 1998 · Biochemical and Biophysical Research Communications
59. Overexpression of Her-2/Neu may be an Indicator of Poor Prognosis in Prostate Cancer
    Raj Sadasivan, R.J. Morgan, Scott B. Jennings · 1993 · The Journal of Urology
60. Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat.
    A. Stuart Wright, Lynn N. Thomas, R.C. Douglas, Catherine B. Lazier, Roger S. Rittmaster · 1996 · Journal of Clinical Investigation
61. Surprising Activity of Flutamide Withdrawal, When Combined With Aminoglutethimide, in Treatment of "Hormone-Refractory" Prostate Cancer
    Oliver A. Sartor, Michael Robert Cooper, M. Weinberger, Donna J. Headlee, Alain Thibault, Anne C. Tompkins, Seth M. Steinberg, William Douglas Figg, William Marston Linehan, C. E. Myers · 1994 · JNCI Journal of the National Cancer Institute
62. Susceptibility to prostate cancer: interaction between genotypes at the androgen receptor and prostate-specific antigen loci.
    Wenmei Xue, Ryan A. Irvine, M C Yu · 2000 · PubMed
63. STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP
    Michael T. Spiotto, Theodore D. Chung · 2000 · The Prostate
64. Pathological changes in benign and malignant prostatic tissue following androgen deprivation therapy
    Victor E. Reuter · 1997 · Urology
65. Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease
    Veronica C. Nwosu · 2001 · Human Molecular Genetics
66. Overexpression of Insulin-Like Growth Factor Binding Protein-5 Helps Accelerate Progression to Androgen-Independence in the Human Prostate LNCaP Tumor Model through Activation of Phosphatidylinositol 3'-Kinase Pathway
    Hideaki Miyake · 2000 · Endocrinology
67. Family history and prostate cancer risk in a population-based cohort of Iowa men.
    James R. Cerhan, Alexander Scott Parker, Shannon D. Putnam, Brian C.‐H. Chiu, Charles F. Lynch, Michael B. Cohen, James C. Torner, Kenneth P. Cantor · 1999 · PubMed
68. Hormone Status Selects for Spontaneous Somatic Androgen Receptor Variants That Demonstrate Specific Ligand and Cofactor Dependent Activities in Autochthonous Prostate Cancer
    Guangzhou Han, Barbara A. Foster, Sandeep G. Mistry, Grant Buchanan, Jonathan M. Harris, Wayne D. Tilley, Norman M. Greenberg · 2001 · Journal of Biological Chemistry
69. Induction of prostate specific antigen production by steroids and tamoxifen in breast cancer cell lines
    He Yu, Eleftherios P. Diamandis, Nosratollah Zarghami, Linda Grass · 1994 · Breast Cancer Research and Treatment
70. Determinants of age at menarche as early life predictors of breast cancer risk
    Eleni Th. Petridou, E Katerini I. Syrigou, Nektaria Toupadaki, Xenofon Zavitsanos, Walter Churchill Willett, Dimitrios Trichopoulos · 1996 · International Journal of Cancer
71. Production of epidermal growth factor and transforming growth factor‐α by the androgen‐responsive LNCaP human prostate cancer cell line
    Jeanne M. Connolly, David P. Rose · 1990 · The Prostate
72. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Yan Guo, Natasha Kyprianou · 1998 · PubMed
73. Overexpression of Cdc25B, an androgen receptor coactivator, in prostate cancer
    Esw Ngan, Yoshihiro Hashimoto, Zhi-Qing Ma, Ming‐Jer Tsai, Sophia Y. Tsai · 2003 · Oncogene
74. Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line
    Victoria Lin Bae-Jump, Colleen K. Jackson‐Cook, Susan J. Maygarden, Stephen R. Plymate, Juza Chen, Joy L. Ware · 1998 · The Prostate
75. Low Dose Ketoconazole With Replacement Doses of Hydrocortisone in Patients With Progressive Androgen Independent Prostate Cancer
    Katherine A. Harris, VIVIAN K. WEINBERG, Robert Bok, Mika Kakefuda Derynck, Eric Jay Small · 2002 · The Journal of Urology
76. RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cells
    Dharminder Chauhan, Teru Hideshima, Pramod Pandey et al. · 1999 · Oncogene
77. On the prevention and therapy of prostate cancer by androgen administration.
    Richmond T. Prehn · 1999 · PubMed
78. Antiandrogen Effects of Mifepristone on Coactivator and Corepressor Interactions with the Androgen Receptor
    Liang‐Nian Song, Meghan Coghlan, Edward Paul Gelmann · 2003 · Molecular Endocrinology
79. CXC-chemokines stimulate invasion and chemotaxis in prostate carcinoma cells through the CXCR2 receptor
    Jane Reiland, Leo T. Furcht, James B. McCarthy · 1999 · The Prostate
80. Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator.
    Kazuo Nishimura, Huei‐Ju Ting, Yasunori Harada, Takashi Tokizane, Norio Nonomura, Hong‐Yo Kang, Hong‐Chiang Chang, Shuyuan Yeh, Hiroshi Miyamoto, Masaru Shin et al. · 2003 · PubMed
81. Insulin-like growth factor-binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostate.
    Marie K. Tennant, James Brantley Thrasher, Patrick A. Twomey · 1996 · The Journal of Clinical Endocrinology & Metabolism
82. Endocrine treatment of prostate cancer
    Teuvo L.J. Tammela · 2004 · The Journal of Steroid Biochemistry and Molecular Biology
83. Prostate Volume and Growth in Testosterone-Substituted Hypogonadal Men Are Dependent on the CAG Repeat Polymorphism of the Androgen Receptor Gene: A Longitudinal Pharmacogenetic Study
    Michael Zitzmann, Marion Depenbusch, Jörg Gromoll, Eberhard Nieschlag · 2003 · The Journal of Clinical Endocrinology & Metabolism
84. Antagonism between PTEN/MMAC1/TEP-1 and Androgen Receptor in Growth and Apoptosis of Prostatic Cancer Cells
    Pengfei Li, Santo V. Nicosia, Wenlong Bai · 2001 · Journal of Biological Chemistry
85. Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/pT3 prostate cancer
    Dagmar Strohmeyer, Christian R�ssing, Franz Strauss, Anja Bauerfeind, Olaf Kaufmann, Stefan A. Loening · 2000 · The Prostate
86. Differential Modulation of Androgen Receptor-mediated Transactivation by Smad3 and Tumor Suppressor Smad4
    Hong‐Yo Kang, Ko‐En Huang, Shiuh‐Young Chang, Wen‐Lung Ma, Wen‐Jye Lin, Chawnshang Chang · 2002 · Journal of Biological Chemistry
87. Immunocytochemical analysis of androgen receptor along the ducts of the separate rat prostate lobes after androgen withdrawal and replacement.
    Gail S. Prins, Lynn A. Birch · 1993 · Endocrinology
88. Insulin-like Growth Factors and Prostate Cancer
    Michaël Pollak · 2001 · Epidemiologic Reviews
89. Elevation of cyclic adenosine 3',5'-monophosphate potentiates activation of mitogen-activated protein kinase by growth factors in LNCaP prostate cancer cells.
    Taosheng Chen, R W Cho, Philip A. Stork, Michael J. Weber · 1999 · PubMed
90. Androgen Receptor Alterations in Prostate Cancer Relapsed during a Combined Androgen Blockade by Orchiectomy and Bicalutamide
    Kyllikki Haapala, EIJA-R. HYYTINEN, Mikko Roiha · 2001 · Laboratory Investigation
91. Supervillin associates with androgen receptor and modulates its transcriptional activity
    Huei‐Ju Ting, Shuyuan Yeh, Kazuo Nishimura, Chawnshang Chang · 2002 · Proceedings of the National Academy of Sciences
92. A C619Y Mutation in the Human Androgen Receptor Causes Inactivation and Mislocalization of the Receptor with Concomitant Sequestration of SRC-1 (Steroid Receptor Coactivator 1)
    Lynne V. Nazareth, David L. Stenoien, William E. Bingman, Alaina J. James, Carol A. Wu, Yixian Zhang, Dean P. Edwards, Michael A. Mancini, Marco Marcelli, Dolores J. Lamb et al. · 1999 · Molecular Endocrinology
93. Characterization of ESE-2, a Novel ESE-1-related Ets Transcription Factor That Is Restricted to Glandular Epithelium and Differentiated Keratinocytes
    Peter Oettgen, Koen Kas, Antoinise Dube, Xuesong Gu, Frank Grall, Usanee Thamrongsak, Yasmin Akbarali, Eduardo Finger, Jay Boltax, Greg Endress et al. · 1999 · Journal of Biological Chemistry
94. Interrogating androgen receptor function in recurrent prostate cancer.
    Liqun Zhang, Mai Johnson, Kim H Le, Makoto Sato, Romyla Ilagan, Meera R. Iyer, Sanjiv Sam Gambhir, Lily Wu, Michael Carey · 2003 · PubMed
95. ADENOCARCINOMA OF PROSTATE IN 40-YEAR-OLD BODY-BUILDER
    James Allen Roberts · 1986 · The Lancet
96. Effect of a short CAG (glutamine) repeat on human androgen receptor function
    Dacheng Ding, Lihua Xu, Mani Menon, G. Prem Veer Reddy, Evelyn R. Barrack · 2003 · The Prostate
97. The Development of a Male Pseudohermaphroditic Rat Using an Inhibitor of the Enzyme 5α-Reductase*
    Julianne Imperato‐McGinley, ZBIGNIEW K. BINIENDA, A. B. Arthur, David T. Mininberg, E. Darracott Vaughan, Fred William Quimby · 1985 · Endocrinology
98. Androgen and estrogen signaling at the cell membrane via G-proteins and cyclic adenosine monophosphate
    W Rosner · 1999 · Steroids
99. Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX.
    Ethan M. Lange, Hong Chen, Kristin Brierley · 1999 · PubMed
100. PROSTATIC INDUCTION: INTERACTION OF EPITHELIUM AND MESENCHYME FROM NORMAL WILD-TYPE MICE AND ANDROGEN-INSENSITIVE MICE WITH TESTICULAR FEMINIZATION
     Ilse Lasnitzki, Takeo Mizuno · 1980 · Journal of Endocrinology
101. Steroids in Fluids and Sperm Entering and Leaving the Bovine Epididymis, Epididymal Tissue, and Accessory Sex Gland Secretions1
     Venkataseshu K. Ganjam, RUPERT P. AMANN · 1976 · Endocrinology
102. Induction of Senescence-Like Phenotypes by Forced Expression of hic-5, Which Encodes a Novel LIM Motif Protein, in Immortalized Human Fibroblasts
     Motoko Shibanuma, Emi Mochizuki, Rika Maniwa, Jun‐ichi Mashimo, Naoyuki Nishiya, Shin‐ichiro Imai, Toshiya Takano, Mitsuo Oshimura, Kiyoshi Nose · 1997 · Molecular and Cellular Biology
103. Hic-5-Reduced Cell Spreading on Fibronectin: Competitive Effects between Paxillin and Hic-5 through Interaction with Focal Adhesion Kinase
     Naoyuki Nishiya, Kouichi Tachibana, Motoko Shibanuma, Jun‐ichi Mashimo, Kiyoshi Nose · 2001 · Molecular and Cellular Biology
104. Oral Contraceptive-induced Expression of Prostate-specific Antigen in the Female Breast
     He Yu, Eleftherios P. Diamandis, Maria Itria Monne · 1995 · Journal of Biological Chemistry
105. Regulation of Stat3 Activation by MEK Kinase 1
     Cheh Peng Lim, Xinmin Cao · 2001 · Journal of Biological Chemistry
106. Estradiol Activates the Prostate Androgen Receptor and Prostate-specific Antigen Secretion through the Intermediacy of Sex Hormone-binding Globulin
     Atif M. Nakhla, Nicholas A. Romas, William Rosner · 1997 · Journal of Biological Chemistry
107. The effects of androgen deprivation on the prostate gland: cell death mediated by vascular regression
     Ralph O'Toole Buttyan, Mohamed A. Abdel Ghafar, Ahmad Shabsigh · 2000 · Current Opinion in Urology
108. Sex Hormone-Binding Globulin: Not only a transport protein. What news is around the corner?
     Nicoletta Fortunati · 1999 · Journal of Endocrinological Investigation
109. The androgen receptor gene and its influence on the development and progression of prostate cancer
     Jeffrey Scott Montgomery, Douglas K. Price, William Douglas Figg · 2001 · The Journal of Pathology
110. SV40 DNA in human osteosarcomas shows sequence variation among T-antigen genes
     John A. Lednicky, A. Renee Stewart, Jesse J. Jenkins, Milton J. Finegold, Janet S. Butel · 1997 · International Journal of Cancer
111. Prevalence of androgen receptor gene mutations in latent prostatic carcinomas from Japanese men.
     Hiroyuki Takahashi, Masakuni Furusato, William C. Allsbrook, H Nishii, Shin Wakui, J C Barrett, Jeff A. Boyd · 1995 · PubMed
112. Effect of culture conditions on androgen sensitivity of the human prostatic cancer cell line LNCaP
     Erna G. Langeler, C.J.C. van Uffelen, Marinus A. Blankenstein, Gert Jan van Steenbrugge, Eppo Mulder · 1993 · The Prostate
113. Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP.
     Pirkko M. A. Henttu, Pirkko Vihko · 1993 · PubMed
114. Vitamin D analogue EB1089-induced prostate regression is associated with increased gene expression of insulin-like growth factor binding proteins
     Tara Nickerson, Hung The Huynh · 1999 · Journal of Endocrinology
115. Effects of mitogens on androgen receptor-mediated transactivation
     P. Reinikainen, Jorma J. Palvimo, Olli A. Jänne · 1996 · Endocrinology
116. Both Androgen Receptor and Glucocorticoid Receptor Are Able to Induce Prostate-Specific Antigen Expression, but Differ in Their Growth-Stimulating Properties of LNCaP Cells*
     C.B.J.M. Cleutjens, Karine Steketee, Conny C. Ehren-van Eekelen · 1997 · Endocrinology
117. Sex hormone-binding globulin receptor signal transduction proceeds via a G protein
     Atif M. Nakhla, James N. Leonard, Daniel J. Hryb, William Rosner · 1999 · Steroids
118. The dynamic and elusive membrane estrogen receptor-α
     Cheryl S. Watson, Celeste H. Campbell, Bahiru Gametchu · 2002 · Steroids
119. Specific high-affinity binding of peripheral benzodiazepine receptor ligands to brain tumors in rat and man
     Keith L. Black, Kiyonobu Ikezaki, Emily M. Santori, Donald P. Becker, Harry V. Vinters · 1990 · Cancer
120. Expression of the extracellular matrix signaling molecule Cyr61 is downregulated in prostate cancer
     Christian P. Pilarsky, U. Schmidt, Claudia Eißrich, J. Stade, Stefan E. Froschermaier, Michael Haase, Gerhard Faller, Thomas Kirchner, Manfred Peter Wirth · 1998 · The Prostate
121. Identification and Characterization of a Tissue-Specific Coactivator, GT198, That Interacts with the DNA-Binding Domains of Nuclear Receptors
     Lan Ko, Guemalli R. Cardona, Alexandra Henrion‐Caude, William W. Chin · 2002 · Molecular and Cellular Biology
122. Attenuation of Ras signaling restores androgen sensitivity to hormone-refractory C4-2 prostate cancer cells.
     Robert E. Bakin, Daniel G. Gioeli, Eric A. Bissonette, Michael J. Weber · 2003 · PubMed
123. Three-Month Treatment With a Long-Acting Gonadotropin-Releasing Hormone Agonist of Patients With Benign Prostatic Hyperplasia: Effects on Tissue Androgen Concentration, 5α-Reductase Activity and Androgen Receptor Content*
     Gianni Forti, ROBERTO SALERNO, Gloriano Moneti, SONIA ZOPPI, Gianna Fiorelli, TARCISIO MARINONI, Alessandro Natali, ALFIERO COSTANTINI, Mario Serio, Luciano Martini et al. · 1989 · The Journal of Clinical Endocrinology & Metabolism
124. Molecular basis for the antiandrogen withdrawal syndrome
     Hiroshi Miyamoto, Mujib M. Rahman, Chawnshang Chang · 2003 · Journal of Cellular Biochemistry
125. Androgen and glucocorticoid receptors in the stroma and epithelium of prostatic hyperplasia and carcinoma.
     James Lloyd Mohler, Y Chen, Katherine G. Hamil, Susan H. Hall, John Anthony Cidlowski, Elizabeth M. Wilson, Frank S. French, Madhabanada Sar · 1996 · PubMed
126. BRCA2 cooperates with histone acetyltransferases in androgen receptor-mediated transcription
     Sook Shin, Inder M. Verma · 2003 · Proceedings of the National Academy of Sciences
127. Evaluation of Ligand-Dependent Changes in AR Structure Using Peptide Probes
     Ching‐yi Chang, Donald Patrick McDonnell · 2002 · Molecular Endocrinology
128. The effects of chronic high dose androgen or estrogen treatment on the human prostate [corrected].
     Bo Jin, Leo Turner, W.A.W. Walters, David J. Handelsman · 1996 · The Journal of Clinical Endocrinology & Metabolism
129. Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene.
     Nina Mononen, Kirsi Syrjäkoski, Mika P. Matikainen, Teuvo L.J. Tammela, Johanna Schleutker, Olli Kallioniemi, Jan Trapman, Pasi A. Koivisto · 2000 · PubMed
130. The Transcriptional Co-Activator cAMP Response Element-Binding Protein-Binding Protein Is Expressed in Prostate Cancer and Enhances Androgen- and Anti-Androgen-Induced Androgen Receptor Function
     Barbara Comuzzi, Leonidas Lambrinidis, Hermann Rogatsch, Sonia Godoy‐Tundidor, Nikola Knežević, Ivan Krhen, Z Mareković, Georg Hans Bartsch, Helmut Klocker, Alfred Hobisch et al. · 2003 · American Journal Of Pathology
131. Identification of amplified and expressed genes in breast cancer by comparative hybridization onto microarrays of randomly selected cDNA clones
     Jeremy Clark, S M Edwards, M. Mariadason John et al. · 2002 · Genes Chromosomes and Cancer
132. Interaction of epidermal growth factor and transforming growth factor beta in human prostatic epithelial cells in culture
     Debra M. Sutkowski, Chau‐Jye Fong, Julia A. Sensibar · 1992 · The Prostate
133. High frequency of mutator phenotype in human prostatic adenocarcinoma.
     Xiang Gao, Ning Wu, David J. Grignon · 1994 · PubMed
134. Mutant androgen receptors in prostatic tumors distinguish between amino‐acid‐sequence requirements for transactivation and ligand binding
     Heike Peterziel, Zoran Čulig, Jutta Stober, Alfred Hobisch, Christian Radmayr, Georg Hans Bartsch, Helmut Klocker, Andrew C.B. Cato · 1995 · International Journal of Cancer
135. Suppression of Pyk2 Kinase and Cellular Activities by Fip200
     Hiroki R. Ueda, Smita Abbi, Chuanhai Zheng, Jun‐Lin Guan · 2000 · The Journal of Cell Biology
136. Differential Regulation of Androgen and Glucocorticoid Receptors by Retinoblastoma Protein
     Jianming Lü, Mark Danielsen · 1998 · Journal of Biological Chemistry
137. Synergistic activation of androgen receptor by androgen and luteinizing hormone-releasing hormone in prostatic carcinoma cells
     Zoran Čulig, Alfred Hobisch, A Hittmair, Marcus Victor Cronauer, Christian Radmayr, Ju Zhang, Georg Hans Bartsch, Helmut Klocker · 1997 · The Prostate
138. Cross-Talk between Signal Transducer and Activator of Transcription 3 and Androgen Receptor Signaling in Prostate Carcinoma Cells
     Tadashi Matsuda, Akira Junicho, Tetsuya Yamamoto, Hiroyuki Kishi, Kemal Korkmaz, Fahri Saatcioglu, Hideki Fuse, Atsushi Muraguchi · 2001 · Biochemical and Biophysical Research Communications
139. Receptors for androgen-binding proteins: Internalization and intracellular signalling
     Catarina Segreti Porto, Maria Fatima Magalhães Lazari, Lygia C. Abreu, C. Wayne Bardin, Glen L. Gunsalus · 1995 · The Journal of Steroid Biochemistry and Molecular Biology
140. Genomic instability in neoplasia
     Ronald Honchel, Kevin C. Halling, Stephen N. Thibodeau · 1995 · Seminars in Cell Biology
141. Androgen Receptor Expression and Cellular Proliferation During Transition from Androgen-Dependent to Recurrent Growth after Castration in the CWR22 Prostate Cancer Xenograft
     Desok Kim, Christopher W. Gregory, Frank S. French, Gary J. Smith, James Lloyd Mohler · 2002 · American Journal Of Pathology
142. Gene activity during the early phase of androgen-stimulated rat prostate regrowth.
     Aaron E. Katz, M C Benson, Gilbert J. Wise · 1989 · PubMed
143. Sex Hormone-Binding Globulin Mediates Prostate Androgen Receptor Action via a Novel Signaling Pathway
     Victor D. H. Ding, David E. Moller, William P. Feeney, Varsha Didolkar, Atif M. Nakhla, Linda Rhodes, William Rosner, Roy G. Smith · 1998 · Endocrinology
144. The effect of environmental cues on the differentiation of myofibroblasts in peritoneal granulation tissue
     2000
145. Benefits of Combination Therapy with Flutamide in Patients Relapsing after Castration
     Fernand Labrie, A. Dupont, M. Giguère, Jean-Pierre Borsanyi, Yves Lacourcière, G. Monfette, Jean Emond, Nicole Bergeron · 1988 · British Journal of Urology
146. Hydroxyflutamide may not always be a pure antiandrogen
     Shuyuan Yeh, Hiroshi Miyamoto, Chawnshang Chang · 1997 · The Lancet
147. Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi's sarcoma cells.
     Z Y Liu, Ramesh Kumar Ganju, J F Wang, Mel A. Ona, William C. Hatch, T. Zheng, S Avraham, Parkash S. Gill, Jerome E. Groopman · 1997 · Journal of Clinical Investigation
148. BRCA1 and BRCA2 have a limited role in familial prostate cancer.
     Colleen Schehl Sinclair, Rebecca M. Berry, Dan Schaid · 2000 · PubMed
149. Analysis of cyclin-dependent kinase inhibitor expression and methylation patterns in human prostate cancers
     TuDung T. Nguyen, Carvell T. Nguyen, Felicidad A. Gonzales, Peter W. Nichols, Mimi C. Yu, Peter A. Jones · 2000 · The Prostate
150. Regulation of Apoptosis in the Prostate Gland by Androgenic Steroids
     Ralph Buttyan, Ahmad Shabsigh, Harris Perlman · 1999 · Trends in Endocrinology and Metabolism
151. Comparative Aspects of Prostatic Growth and Androgen Metabolism with Aging in the Dog Versus the Rat*
     Stephen J. Berry, John T. Isaacs · 1984 · Endocrinology
152. Increase of chemotherapy use in older women with breast carcinoma from 1991 to 1996
     Xianglin L. Du, James S. Goodwin · 2001 · Cancer
153. A Dominant-negative Mutant of Androgen Receptor Coregulator ARA54 Inhibits Androgen Receptor-mediated Prostate Cancer Growth
     Hiroshi Miyamoto, Mujib Rahman, Hiroshi Takatera, Hong‐Yo Kang, Shuyuan Yeh, Hong‐Chiang Chang, Kazuo Nishimura, Naohiro Fujimoto, Chawnshang Chang · 2002 · Journal of Biological Chemistry
154. A potential autocrine loop between heregulin‐alpha and erbB‐3 receptor in human prostatic adenocarcinoma
     Hing Y. Leung, J. Weston, William John Gullick · 1997 · British Journal of Urology
155. Clinical review 37: Endocrine treatment of prostate cancer.
     Richard J. Santen · 1992 · The Journal of Clinical Endocrinology & Metabolism
156. Genetic determinants of serum prostate-specific antigen levels in healthy men from a multiethnic cohort.
     Wenmei Xue, Gerhard A. Coetzee, Ronald K. Ross · 2001 · PubMed
157. Variable expressivity and mutation databases: The androgen receptor gene mutations database
     Bruce Gottlieb, Lenore K. Beitel, Mark A. Trifiro · 2001 · Human Mutation
158. The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel
     A. Vazina, J. Baniel, Y. Yaacobi, A. Shtriker, D. Engelstein, I. Leibovitz, M. Zehavi, A. Sidi, Y. Ramon, T. Tischler et al. · 2000 · British Journal of Cancer
159. Insulin-like growth factor-binding proteins (IGFBP)-4, -5, and -6 in the benign and malignant human prostate: IGFBP-5 messenger ribonucleic acid localization differs from IGFBP-5 protein localization.
     Marie K. Tennant, James Brantley Thrasher, Patrick A. Twomey · 1996 · The Journal of Clinical Endocrinology & Metabolism
160. Inactivation of androgen receptor coregulator ARA55 inhibits androgen receptor activity and agonist effect of antiandrogens in prostate cancer cells
     Mujib M. Rahman, Hiroshi Miyamoto, Henry A. Lardy, Chawnshang Chang · 2003 · Proceedings of the National Academy of Sciences
161. Prostate‐specific antigen, clinical use and staging: an overview
     Ulf‐Håkan Stenman · 1997 · British Journal of Urology
162. Response of prostate cancer cells to peptide growth factors: transforming growth factor-beta.
     George Wilding · 1991 · PubMed
163. Differential telomerase activity, expression of the telomerase catalytic sub-unit and telomerase-RNA in ovarian tumors
     Tjoung‐Won Park, Sabine Riethdorf, Lutz Riethdorf, Thomas L�ning, Fritz J�nicke · 1999 · International Journal of Cancer
164. Suppression of Androgen Receptor Transactivation by Pyk2 via Interaction and Phosphorylation of the ARA55 Coregulator
     Xin Wang, Yue Yang, Xiaojian Guo, Erik R. Sampson, Cheng-Lung Hsu, Meng-Yin Tsai, Shuyuan Yeh, Guan Wu, Yinglu Guo, Chawnshang Chang · 2002 · Journal of Biological Chemistry
165. APPL Suppresses Androgen Receptor Transactivation via Potentiating Akt Activity
     Lin Yang, Hui-Kuan Lin, Saleh Altuwaijri, Shaozhen Xie, Liang Wang, Chawnshang Chang · 2003 · Journal of Biological Chemistry
166. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells.
     Yi Fen Lee, Wen Jye Lin, Jiaoti Huang · 2002 · PubMed
167. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
     A Brändström, Patrick Westin, Anders R. J. Bergh · 1994 · PubMed
168. Expression of novel genes linked to the androgen-induced, proliferative shutoff in prostate cancer cells
     P Geck, József Szelei, Jesús Jiménez, Tien‐Min Lin, Carlos Sonnenschein, Ana Maria Soto · 1997 · The Journal of Steroid Biochemistry and Molecular Biology
169. Association of polymorphisms within androgen receptor, 5α‐reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly men
     Georg Schatzl, Stephan Madersbacher A, Andrea Gsur, Martin Preyer, Gerald Haidinger, Andrea Haitel, Christian Vutuc, M. Micksche, Michael Marberger · 2002 · The Prostate
170. Inhibition of growth and induction of apoptosis by androgens of a variant of LNCaP cell line
     Marie-Odile Joly-Pharaboz, A. Ruffion, A.M. Roch · 2000 · The Journal of Steroid Biochemistry and Molecular Biology
171. Clinical significance of elevation in neuroendocrine factors and interleukin-6 in metastatic prostate cancer
     Naseema M. Hoosein, Mansoor Abdul, Richard McCabe · 1995 · Urologic Oncology Seminars and Original Investigations
172. Domain Interactions between Coregulator ARA70 and the Androgen Receptor (AR)
     Zhong-xun Zhou, Bin He, Susan H. Hall, Elizabeth M. Wilson, Frank S. French · 2002 · Molecular Endocrinology
173. Polymorphic repeats in the androgen receptor gene in high‐risk sibships
     Elizabeth A. Miller, Janet L. Stanford, Li Hsu · 2001 · The Prostate
174. BRCA1 and Prostate Cancer
     Eliot M. Rosen, Saijun Fan, Itzhak D. Goldberg · 2001 · Cancer Investigation
175. Variations of Proline-Rich Kinase Pyk2 Expression Correlate with Prostate Cancer Progression
     Rosita Stanzione, Antonietta Picascia, Paolo Chieffi et al. · 2001 · Laboratory Investigation
176. 55 kDa nuclear matrix protein (nmt55) mRNA is expressed in human prostate cancer tissue and is associated with the androgen receptor
     Hitoshi Ishiguro, Hiroji Uemura, Kiyoshi Fujinami · 2003 · International Journal of Cancer
177. Androgen receptor expression induces FGF2, FGF‐binding protein production, and FGF2 release in prostate carcinoma cells: Role of FGF2 in growth, survival, and androgen receptor down‐modulation
     Paolo Rosini, Lorella Bonaccorsi, Elisabetta Baldi, Chiara Chiasserini, Gianni Forti, Giovanna De Chiara, Maria Lucibello, Maurizio Mongiat, Renato V. Iozzo, Enrico Garaci et al. · 2002 · The Prostate
178. Hormone and antihormone withdrawal: implications for the management of androgen-independent prostate cancer
     Howard I. Scher, Zuo‐Feng Zhang, David M. Nanus, William Kevin Kelly · 1996 · Urology
179. Amplification of the androgen receptor may not explain the development of androgen‐independent prostate cancer
     Joanne Edwards, N. Sarath Krishna, R. Mukherjee · 2001 · British Journal of Urology
180. Prostate cancer: a comprehensive review
     SN Pentyala, J Lee, Kisseng Hsieh · 2000 · Medical Oncology
181. Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP
     Marie-Odile Joly-Pharaboz, Marie-C. Soave, Brigitte Nicolas · 1995 · The Journal of Steroid Biochemistry and Molecular Biology
182. Reducing the Agonist Activity of Antiandrogens by a Dominant-negative Androgen Receptor Coregulator ARA70 in Prostate Cancer Cells
     Mujib M. Rahman, Hiroshi Miyamoto, Hiroshi Takatera, Shuyuan Yeh, Saleh Altuwaijri, Chawnshang Chang · 2003 · Journal of Biological Chemistry
183. Identification of two germline point mutations in the 5'UTR of the androgen receptor gene in men with prostate cancer.
     Laura E. Crocitto, B E Henderson, Gerhard A. Coetzee · 1997 · PubMed
184. Proline-rich tyrosine kinase 2 regulates proliferation and differentiation of prostate cells
     Antonietta Picascia, Rosita Stanzione, Paolo Chieffi · 2002 · Molecular and Cellular Endocrinology
185. Castration rapidly results in a major reduction in epithelial cell numbers in the rat prostate, but not in the highly differentiated dunning R3327 prostatic adenocarcinoma
     Patrick Westin, Anders R. J. Bergh, Jan‐Erik Damber · 1993 · The Prostate
186. Autoimmune anti-androgen-receptor antibodies in human serum.
     Shutsung Liao, Daniel R. Witte · 1985 · Proceedings of the National Academy of Sciences
187. Phosphorylation of Hic‐5 at tyrosine 60 by CAKβ and Fyn
     Masaho Ishino, Hiroshi Aoto, Hiroko Sasaski · 2000 · FEBS Letters
188. Androgen Receptor Gene Polymorphism and Prostate Zonal Volumes in Australian and Chinese Men
     Bo Jin, Jonathan Beilin, Jeffrey D. Zajac, David J. Handelsman · 2000 · Journal of Andrology
189. Immunohistochemical expression of transforming growth factor beta 1 and nm-23 H1 antioncogene in prostate cancer: divergent correlation with clinicopathological parameters.
     KONSTANTINOS G. STRAVODIMOS, Constantinos A. Constantinides, THEODOROS MANOUSAKAS · 2001 · PubMed
190. Parenteral polyoestradiol phosphate vs orchidectomy in the treatment of advanced prostatic cancer. Efficacy and cardiovascular complications: a 2‐year follow‐up report of a national, prospective prostatic cancer study
     Mikkola, Ruutu Ruutu, Ruutu · 1998 · British Journal of Urology
191. Merkel cells in the human oesophagus
     J. L. Harmse, Francis A. Carey, A. Baird, S. Craig, K. N. Christie, D. Hopwood, John M. Lucocq · 1999 · Journal of Pathology
192. Insulin-like growth factor-binding proteins (IGFBP)-4, -5, and -6 in the benign and malignant human prostate: IGFBP-5 messenger ribonucleic acid localization differs from IGFBP-5 protein localization
     M. K. Tennant · 1996 · The Journal of Clinical Endocrinology & Metabolism
193. Progress in active specific immunotherapy of prostate cancer
     Benjamin A. Tjoa, Gerald P. Murphy · 2000 · Seminars in Surgical Oncology
194. Regulation of Bcl-2 Expression by Dihydrotestosterone in Hormone Sensitive LNCaP-FGC Prostate Cancer Cells
     Elizabeth M. Bruckheimer, Kevin B. Spurgers, Nancy L. Weigel, Christopher J. Logothetis, Timothy J. McDonnell · 2003 · The Journal of Urology
195. Unusual presentation of extranodal peripheral T-cell lymphomas with multiple paraneoplastic features
     José Luis Díez-Martín, John Anthony Lust, Thomas Elmer Witzig, Peter M. Banks, Chin-Yang Li · 1991 · Cancer
196. A Proliferative Effect of Transforming Growth Factor-β1 on a Human Prostate Cancer Cell Line, TSU-Pr1
     Marilyn L. G. Lamm, Sharon M. Sintich, Chung Lee · 1998 · Endocrinology
197. The Human Membrane Progesterone Receptor Gene: Genomic Structure and Promoter Analysis
     Sabine Bernauer, Martin Wehling, Dirk Gerdes And, Elisabeth Falkenstein · 2001 · DNA sequence
198. Modulation of androgen receptor (AR)-mediated transcriptional activity by EGF in the developing mouse reproductive tract primary cells
     Chhanda Gupta · 1999 · Molecular and Cellular Endocrinology
199. RAFTK/Pyk2 involvement in platelet activation is mediated by phosphoinositide 3‐kinase
     Katarzyna Koziak, Elżbieta Kaczmarek, Shin‐Young Park · 2001 · British Journal of Haematology
200. IDENTIFICATION OF TWO GERMLINE POINT MUTATIONS IN THE 5′UTR OF THE ANDROGEN RECEPTOR GENE IN MEN WITH PROSTATE CANCER
     Laura E. Crocitto, Brian E. Henderson, Gerhard A. Coetzee · 1997 · The Journal of Urology